Bevacizumab impairs oxidative energy metabolism and shows antitumoral effects in recurrent glioblastomas: a (31)P/(1)H MRSI and quantitative magnetic resonance imaging study

Bevacizumab shows unprecedented rates of response in recurrent glioblastomas (GBM), but the detailed mechanisms are still unclear. We employed in vivo magnetic resonance spectroscopic imaging (MRSI) and quantitative magnetic resonance imaging to investigate whether bevacizumab alters oxygen and ener...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Hattingen, Elke, Jurcoane, Alina, Bähr, Oliver, Rieger, Johannes, Magerkurth, Jörg, Anti, Sandra, Steinbach, Joachim P., Pilatus, Ulrich
Médium: Artigo
Jazyk:Inglês
Vydáno: Oxford University Press 2011
Témata:
Clinical Investigations
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3223092/
https://ncbi.nlm.nih.gov/pubmed/21890539
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nor132
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky